Stay updated on Daratumumab Therapy for Refractory AL Amyloidosis Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Therapy for Refractory AL Amyloidosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Therapy for Refractory AL Amyloidosis Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:09:54.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version (v2.15.0) and the removal of detailed information about a Phase II study of Daratumumab in AL Amyloidosis patients, including treatment protocols and eligibility criteria.
    Difference
    48%
    Check dated 2025-04-23T23:08:18.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T13:56:40.000Z thumbnail image
  6. Check
    81 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    2%
    Check dated 2025-02-24T22:55:52.000Z thumbnail image
  7. Check
    96 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    2%
    Check dated 2025-02-10T16:04:21.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T11:13:37.000Z thumbnail image

Stay in the know with updates to Daratumumab Therapy for Refractory AL Amyloidosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Therapy for Refractory AL Amyloidosis Clinical Trial page.